Physicians realty trust (DOC)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash Flows from Operating Activities:
Net income

77,186

58,321

39,773

31,522

12,741

-4,418

-2,636

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization

146,436

158,389

125,159

86,589

45,471

16,731

5,107

Amortization of deferred financing costs

2,416

2,428

2,299

2,325

1,373

1,097

510

Amortization of lease inducements and above/below-market lease intangibles

4,859

4,659

5,083

3,906

2,577

571

141

Straight-line rental revenue/expense

9,986

21,860

16,202

16,226

9,000

4,366

675

Amortization of discount on unsecured senior notes

603

577

277

0

0

-

-

Amortization of above market assumed debt

-62

-62

-178

-236

-173

0

0

Gain (Loss) on Disposition of Assets

31,309

11,664

5,874

0

130

32

-2

Income (Loss) from Equity Method Investments

-28

114

183

115

104

95

0

Distributions from unconsolidated entities

119

112

210

82

106

71

0

Change in fair value of derivative

-1

6

-150

240

166

161

246

Provision for bad debts

2,206

304

123

2,310

69

9

30

Non-cash share compensation

10,115

8,681

6,695

5,672

3,798

2,422

433

Ziegler shared service amendment payment

-

-

-

-

-

1,800

0

Net change in fair value of contingent consideration

-37

-50

-472

-840

0

0

-

Impairment of Real Estate

0

0

965

0

0

1,750

0

Change in operating assets and liabilities:
Tenant receivables

5,902

-230

2,988

10,058

2,836

986

184

Other assets

2,955

852

533

19,230

2,630

3,518

1,074

Accounts payable to related parties

-

-

-

-

-

-

-1,530

Accounts payable

2,462

-7,137

6,600

3,779

-56

-136

34

Accrued expenses and other liabilities

4,997

16,738

19,567

37,957

8,312

2,556

1,256

Net cash provided by operating activities

201,177

208,694

180,471

127,197

59,352

13,295

1,168

Cash Flows from Investing Activities:
Proceeds on sale of investment properties

20,934

217,222

20,397

0

3,039

235

448

Acquisition of investment properties, net

113,081

236,595

1,268,442

-

-

-

-

Investment in unconsolidated entities

25,954

0

0

1,240,438

752,807

501,127

125,728

Acquisition of noncontrolling interests

1,112

6,406

8,469

4,690

0

-

-

Escrowed cash - acquisition deposits/earnest deposits

10

-2,780

1,280

1,157

-2,000

-

-

Capital expenditures on investment properties

40,137

34,638

23,243

11,304

4,988

900

0

Pay down of contingent consideration

0

0

-156

-483

-999

0

0

Issuances of real estate loans receivable

100,744

11,750

39,063

10,207

22,359

15,386

0

Repayment of real estate loans receivable

7,855

15,928

4,711

11,336

0

0

-

Issuances of note receivable

0

20,385

0

0

20,545

0

0

Repayments of note receivable

0

0

16,423

4,118

0

0

-

Leasing commissions

3,057

3,167

1,449

1,034

579

100

163

Lease inducements

2

172

2,067

8,957

2,478

1,532

1,000

Net cash used in investing activities

-255,308

-77,183

-1,302,638

-1,262,816

-799,716

-518,810

-126,443

Cash Flows from Financing Activities:
Net proceeds from sale of common shares

131,629

10,759

844,669

766,841

545,117

350,384

225,920

Formation transactions

-

-

-

-

-

-

-354

Proceeds from credit facility borrowings

454,000

422,000

927,000

1,181,000

620,000

395,200

52,350

Repayment of credit facility borrowings

330,000

287,000

1,248,000

925,000

363,000

257,200

52,350

Proceeds from issuance of mortgage debt

0

0

61,000

39,500

0

26,550

162

Proceeds from issuance of senior unsecured notes

0

0

743,060

225,000

0

0

-

Principal payments on mortgage debt

25,184

78,018

41,503

10,232

2,022

6,549

41,832

Debt issuance costs

117

4,540

1,589

4,816

3,105

3,887

1,428

OP Unit distributions - General Partner

170,880

168,060

143,108

104,908

63,720

28,104

2,161

OP Unit distributions - Limited Partners

4,838

4,808

4,388

3,162

3,216

3,382

493

Preferred OP Units distributions - Limited Partner

1,176

911

600

1,508

563

0

211

Contributions to noncontrolling interests

572

0

47

0

0

-

-

Distributions to noncontrolling interests - partially owned properties

582

547

748

543

213

185

464

Payments of employee taxes for withheld stock-based compensation shares

-2,076

-1,749

-2,590

-778

-606

-

-

Purchases of Series A Preferred Units

0

0

19,961

9,756

0

0

-

Purchase of Limited Partner Units

14,023

2,203

3,886

3,671

1,088

7,546

0

Common shares repurchased and retired

-

-

-

-

-

321

0

Net cash used in financing activities

37,325

-115,077

1,109,403

1,147,967

727,584

464,960

179,139

Net increase (decrease) in cash and cash equivalents

-16,806

16,434

-12,764

12,348

-12,780

-40,555

53,864

Supplemental cash flow information:
Supplemental disclosure of cash flow information - interest paid during the period

62,633

58,705

38,781

17,151

9,550

5,606

3,942

Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements

-10,112

481

244

13,708

-

0

-

Other Comprehensive Income (Loss), Net of Tax

-

-

-

-

0

-

-

Change in fair value of interest rate swap agreements

-

-

-

-

-

0

-

Supplemental disclosure of noncash activity - assumed debt

0

0

43,989

0

18,690

15,283

0

Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions

-

-

-

-

-

28,589

-

Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions

25,200

22,651

44,978

6,769

40,376

28,589

11,535

Supplemental disclosure of noncash activity - contingent consideration

0

0

765

156

2,718

840

0

Operating Partnership
Net income

77,186

58,321

39,773

31,522

-

-

-

Depreciation and amortization

146,436

158,389

125,159

86,589

-

-

-

Amortization of deferred financing costs

2,416

2,428

2,299

2,325

-

-

-

Amortization of lease inducements and above/below-market lease intangibles

4,859

4,659

5,083

3,906

-

-

-

Straight-line rental revenue/expense

9,986

21,860

16,202

16,226

-

-

-

Amortization of discount on unsecured senior notes

603

577

277

0

-

-

-

Amortization of above market assumed debt

-62

-62

-178

-236

-

-

-

Income (Loss) from Equity Method Investments

-28

114

183

115

-

-

-

Distributions from unconsolidated entities

119

112

210

82

-

-

-

Change in fair value of derivative

-1

6

-150

240

-

-

-

Provision for bad debts

2,206

304

123

2,310

-

-

-

Non-cash share compensation

10,115

8,681

6,695

5,672

-

-

-

Tenant receivables

5,902

-230

2,988

10,058

-

-

-

Other assets

2,955

852

533

19,230

-

-

-

Accounts payable

2,462

-7,137

6,600

3,779

-

-

-

Accrued expenses and other liabilities

4,997

16,738

19,567

37,957

-

-

-

Net cash provided by operating activities

201,177

208,694

180,471

127,197

-

-

-

Acquisition of investment properties, net

113,081

236,595

1,268,442

-

-

-

-

Escrowed cash - acquisition deposits/earnest deposits

10

-2,780

1,280

1,157

-

-

-

Capital expenditures on investment properties

40,137

34,638

23,243

11,304

-

-

-

Repayment of real estate loans receivable

7,855

15,928

4,711

11,336

-

-

-

Leasing commissions

3,057

3,167

1,449

1,034

-

-

-

Lease inducements

2

172

2,067

8,957

-

-

-

Net cash used in investing activities

-255,308

-77,183

-1,302,638

-1,262,816

-

-

-

Net proceeds from sale of common shares

131,629

10,759

844,669

766,841

-

-

-

Proceeds from credit facility borrowings

454,000

422,000

927,000

1,181,000

-

-

-

Repayment of credit facility borrowings

330,000

287,000

1,248,000

925,000

-

-

-

Principal payments on mortgage debt

25,184

78,018

41,503

10,232

-

-

-

Debt issuance costs

117

4,540

1,589

4,816

-

-

-

OP Unit distributions - General Partner

170,880

168,060

143,108

104,908

-

-

-

OP Unit distributions - Limited Partners

4,838

4,808

4,388

3,162

-

-

-

Preferred OP Units distributions - Limited Partner

1,176

911

600

1,508

-

-

-

Distributions to noncontrolling interests - partially owned properties

582

547

748

543

-

-

-

Payments of employee taxes for withheld stock-based compensation shares

-2,076

-1,749

-2,590

-778

-

-

-

Purchase of Limited Partner Units

14,023

2,203

3,886

3,671

-

-

-

Net cash used in financing activities

37,325

-115,077

1,109,403

1,147,967

-

-

-

Net increase (decrease) in cash and cash equivalents

-16,806

16,434

-12,764

12,348

-

-

-

Supplemental disclosure of cash flow information - interest paid during the period

62,633

58,705

38,781

17,151

-

-

-

Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements

-10,112

481

244

13,708

-

-

-

Physicians Realty L P [Member]
Gain (Loss) on Disposition of Assets

31,309

11,664

5,874

0

-

-

-

Net change in fair value of contingent consideration

-37

-50

-472

-840

-

-

-

Impairment of Real Estate

0

0

965

0

-

-

-

Proceeds on sale of investment properties

20,934

217,222

20,397

0

-

-

-

Investment in unconsolidated entities

25,954

0

0

1,240,438

-

-

-

Acquisition of noncontrolling interests

1,112

6,406

8,469

4,690

-

-

-

Pay down of contingent consideration

0

0

-156

-483

-

-

-

Issuances of real estate loans receivable

100,744

11,750

39,063

10,207

-

-

-

Issuances of note receivable

0

20,385

0

0

-

-

-

Repayments of note receivable

0

0

16,423

4,118

-

-

-

Proceeds from issuance of mortgage debt

0

0

61,000

39,500

-

-

-

Proceeds from issuance of senior unsecured notes

0

0

743,060

225,000

-

-

-

Contributions to noncontrolling interests

572

0

47

0

-

-

-

Purchases of Series A Preferred Units

0

0

19,961

9,756

-

-

-

Supplemental disclosure of noncash activity - assumed debt

0

0

43,989

0

-

-

-

Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions

25,200

22,651

44,978

6,769

-

-

-

Supplemental disclosure of noncash activity - contingent consideration

0

0

765

156

-

-

-